Canada Life’s Assembly Biosciences ASMB Stock Holding History

Canada Life’s Portfolio ASMB Stock Details ASMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-253	Closed	-$14K	–	2565
2021 Q1	$14K	Hold	253	–	–	﹤0.01%	2539
2020 Q4	$18K	Hold	253	–	–	﹤0.01%	2554
2020 Q3	$50K	Hold	253	–	–	﹤0.01%	2179
2020 Q2	$70K	Buy	253 +162	+178%	+$37.8K	﹤0.01%	2137
2020 Q1	$16K	Hold	91	–	–	﹤0.01%	2420
2019 Q4	$22K	Buy	+91	New	+$16.8K	﹤0.01%	2475
2019 Q3	–	Sell	-172	Closed	-$28K	–	1199
2019 Q2	$28K	Buy	+172	New	+$32.7K	﹤0.01%	2549
2019 Q1	–	Sell	-172	Closed	-$45K	–	2621
2018 Q4	$45K	Hold	172	–	–	﹤0.01%	2407
2018 Q3	$77K	Hold	172	–	–	﹤0.01%	2278
2018 Q2	$81K	Hold	172	–	–	﹤0.01%	2260
2018 Q1	$102K	Hold	172	–	–	﹤0.01%	2160
2017 Q4	$93K	Buy	+172	New	+$77.9K	﹤0.01%	2192

Other funds holding ASMB

AIM

Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Canada Life's ASMB Position: Q2 2021 in Review

Canada Life sold out of Assembly Biosciences (ASMB) in Q2 2021, closing a stake of 253 shares — an estimated $14K sold.

Canada Life first reported a position in ASMB in Q4 2017 and held it in 12 quarters. The position peaked at $102K in Q1 2018. 91 funds tracked by Wall St. Rank hold ASMB as of Q2 2021.

Canada Life reported no remaining Assembly Biosciences position as of Q2 2021 after selling out during the quarter.
Canada Life sold 253 Assembly Biosciences shares in Q2 2021, an estimated $14K.
Canada Life first reported a position in Assembly Biosciences in Q4 2017 and held it in 12 quarters.
Canada Life's Assembly Biosciences position peaked at $102K in Q1 2018.
91 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2021.

Based on Canada Life's 13F filing for Q2 2021, filed 11 Aug 2021.